Lexeo Therapeutics announces new executive appointments

  • Lexeo Therapeutics (NASDAQ:LXEO) has announced new executive appointments to lead the evolution of the company’s pipeline into late-stage clinical development.
  • Sandi See Tai, MD, has been promoted to Chief Development Officer.
  • Eric Adler, MD, has been appointed CMO & Head of Research.
  • Rajiv Patni, MD, has been appointed Senior Advisor to the CEO and Board of Directors of Lexeo.
  • Jenny R. Robertson has been appointed Chief Business and Legal Officer.
  • “We look forward to benefiting from this group’s thought leadership and operational experience as we progress the Lexeo pipeline towards late-stage studies.” said aid R. Nolan Townsend, CEO.

Harry Byrne

Related post